|
|||||
|
|
The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practice |
|
| Authors: | Corey K. Bradley Peter Shrader Robert J. Sanchez Eric D. Peterson Ann Marie Navar |
| Affiliation: | 1. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA;2. Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA |
| Abstract: | |
| Keywords: | Corresponding author. Duke Clinical Research Institute, Duke University School of Medicine, 2400 Pratt Street, Durham, NC 27705, USA. Proprotein convertase subtilisin/kexin type 9 PCSK9 inhibitor Utilization Cardiovascular disease Prevention |
| 本文献已被 ScienceDirect 等数据库收录！ | |